RenovoRx Inc.
RNXT | NASDAQ
$1.69
+$0.02 (+1.20%)
Sep 22, 2026, 12:14 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.12M | 43K | n/a | n/a | n/a | n/a |
Cost of Revenue | 327K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 796K | 43K | n/a | n/a | n/a | n/a |
Operating Income | -12.51M | -10.97M | -11.4M | -9.95M | -5.67M | -3.2M |
Interest Income | 427K | 384K | n/a | 57K | 70K | 3K |
Pretax Income | -11.17M | -8.81M | -10.23M | -9.89M | -6.32M | -3.8M |
Net Income | -11.17M | -8.81M | -10.23M | -9.89M | -6.32M | -3.8M |
Selling & General & Admin | 7.04M | 4.99M | 5.73M | 5.65M | 2.63M | 818K |
Research & Development | 6.27M | 6.03M | 5.67M | 4.3M | 3.04M | 2.39M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.31M | 11.01M | 11.4M | 9.95M | 5.67M | 3.2M |
Interest Expense | n/a | n/a | 108K | 57K | 904K | 590K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.63M | 11.01M | 11.4M | 9.95M | 5.67M | 3.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 35.33M | 23.61M | 20.58M | 18.1M | 17.87M | 17.32M |
Shares Outstanding (Diluted) | 35.33M | 23.61M | 20.58M | 18.1M | 17.87M | 17.32M |
EPS (Basic) | -0.32 | -0.37 | -0.50 | -0.54 | -0.40 | -0.25 |
EPS (Diluted) | -0.32 | -0.37 | -0.50 | -0.54 | -0.40 | -0.25 |
EBITDA | -11.17M | -8.81M | -10.12M | -9.83M | -5.48M | n/a |
EBIT | -11.17M | -8.81M | -10.12M | -9.83M | -5.49M | -3.2M |
Depreciation & Amortization | 2K | n/a | 6K | 6K | 9K | 3.2M |
Add to Watchlist
Select watchlists to add or remove RNXT